Shionogi & Co

Shionogi & Co FCF Margin

The Free Cash Flow Margin of Shionogi & Co (4507.T) as of Oct 15, 2026 is 39.85 %. In the previous year, Free Cash Flow Margin was 40.69 % — a change of -2.07% (lower).

FCF Margin

39.85 %

YoY

-2.07%

Last updated:

Free Cash Flow Margin of Shionogi & Co is 2026 39.85 % . Free Cash Flow Margin of Shionogi & Co was 2025 40.69 % . It decreases by -2.07% lower compared to the previous year.

The Shionogi & Co FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2019
43.56 JPY
Jan 1, 2020
36.05 JPY
Jan 1, 2021
25.61 JPY
Jan 1, 2022
21.04 JPY
Jan 1, 2023
32.97 JPY
Jan 1, 2024
32.54 JPY
Jan 1, 2025
40.69 JPY
Jan 1, 2026
39.85 JPY
The Shionogi & Co FCF Margin history
YEARFCF MarginYoY
39.85 %-2.07%
40.69 %+25.03%
32.54 %-1.29%
32.97 %+56.72%
21.04 %-17.84%
25.61 %-28.97%
36.05 %-17.25%
43.56 %+21.18%
35.95 %+20.07%
29.94 %-1.39%
30.36 %+137.93%
12.76 %-49.03%
25.04 %—
Access this data via the Eulerpool API

Shionogi & Co Stock analysis

What does Shionogi & Co do? The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shionogi & Co stock

Free Cash Flow Margin of Shionogi & Co is 39.85 % in 2026.

Free Cash Flow Margin of Shionogi & Co changed from 40.69 % to 39.85 %, representing a -2.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Shionogi & Co since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Shionogi & Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Shionogi & Co

All Key Metrics — Shionogi & Co